Denali Therapeutics Inc (DNLI)
Retained Earnings
-$2.31B
Quarterly · Period ending: · USD
DNLI Retained Earnings
Latest reported-$2.31Bperiod ending
Latest reported-$2.31Bperiod ending
DNLI Quarterly Retained Earnings (-$103.51M → -$2.31B)
Quarterly retained earnings
High-resolution chart · PNG
DNLI retained earnings history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| -2,307,524,000 | |
| -2,179,971,000 | |
| -2,051,524,000 | |
| -1,922,975,000 | |
| -1,796,073,000 | |
| -1,671,954,000 | |
| -1,538,984,000 | |
| -1,424,231,000 | |
| -1,317,039,000 | |
| -1,218,013,000 | |
| -1,116,211,000 | |
| -996,738,000 | |
| -897,385,000 | |
| -1,080,768,000 | |
| -970,987,000 | |
| -872,309,000 | |
| -769,010,000 | |
| -710,216,000 | |
| -644,996,000 | |
| -569,735,000 | |
| -485,147,000 | |
| -424,456,000 | |
| -354,415,000 | |
| -599,300,000 | |
| -541,072,000 | |
| -482,314,000 | |
| -425,551,000 | |
| -371,526,000 | |
| -325,266,000 | |
| -266,929,000 | |
| -227,937,000 | |
| -305,470,000 | |
| -270,099,000 | |
| -215,375,000 | |
| -191,697,000 | |
| -168,810,000 | |
| -146,966,000 | |
| 0 | |
| -103,512,000 |